Navigation Links
Teriflunomide Significantly Reduced Annualized Relapse Rate and was Well Tolerated in MS Patients
Date:8/29/2010

to placebo or teriflunomide, 7mg or 14mg, once daily. The primary endpoint was annualized relapse rate defined as the number of confirmed relapses per patients-year. The key secondary endpoint was the time to disability progression measured by EDSS. Safety and tolerability evaluations were based on treatment emergent adverse events, physical examinations, vital signs and laboratory investigations.

About Multiple Sclerosis

Multiple sclerosis (MS) is a chronic, unpredictable and progressively disabling disease. Patients with MS typically are diagnosed at a young age and they face a lifetime of uncertainty with gradually declining health. Today, over two million people around the world suffer from MS. MS is the result of damage to myelin, a protective sheath surrounding nerve fibres of the central nervous system. When myelin is damaged, this interferes with messages between the brain and other parts of the body. Multiple sclerosis is a very variable condition and the symptoms depend on which areas of the central nervous system have been affected. There is no definite pattern to MS and everyone with MS has a different set of symptoms, which vary from time to time and can change in severity and duration, even in the same person. Management of MS is complex; early intervention in the pathological process is recommended in order to delay disease progression or at least, slow it down. A complex support system is required for the care of MS patients, including health and social services, as well as various healthcare professionals. Although there is no known cure for multiple sclerosis, several therapies are proven to be helpful but there remains an unmet need for new oral therapies with an acceptable benefit/risk profile.

About sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and
'/>"/>

SOURCE Sanofi-aventis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients
2. Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice
3. Bucindolol Significantly Reduces Hospitalization and Death in Heart Failure Patients With Very Favorable Genotypes
4. Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery
5. Study Shows Machine Perfusion Significantly Improves Transplant Results
6. Epilepsia Study Demonstrates New Add-on Antiepileptic Drug Vimpat(R) (lacosamide) Significantly Reduces Partial-Onset Seizures in Adults With Epilepsy
7. New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns
8. Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008
9. PROVENGE Significantly Prolongs Survival in Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
10. Pixantrone Significantly Increases Complete Remissions, Overall Response Rates, Frequency of Durable Remissions and Progression Free Survival in Patients with Relapsed and Refractory Aggressive Non-Hodgkins Lymphoma
11. Buehler Motor, Inc., Significantly Expands Customer and Partner Support in North America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)...  In the farthest reaches of the Amazon rainforest, ... came together in a quest to save their ancestral ... in May in a remote village on the frontier ... concluded over two years work and culminated in the ... by an Amazonian tribe. The 500-page repository details medicinal ...
(Date:7/7/2015)... 2015   Moleculera Labs today announced ... from the Oklahoma Center for the Advancement of ... development and clinical validation of new diagnostic testing ... in patients experiencing neuropsychiatric disorders such as depression, ... to assist physicians in identifying the subset of ...
(Date:7/7/2015)... ... 2015 , ... Since its inception in 2004 PhUSE has ... a conference for European Statistical Programmers, has evolved in the past eleven years ... Programmers, Data Managers and Biostatisticians all over the world, share, contribute and advance ...
(Date:7/7/2015)... ... 07, 2015 , ... The Pistoia Alliance, a global, not-for-profit ... science R&D, has attracted a number of new members from across the industry. ... joining as a Core member, and DNAnexus and Tessella as Participating members. Genexyx ...
Breaking Biology Technology:Amazonian Tribe Creates First Encyclopedia of Indigenous Medicine 2Amazonian Tribe Creates First Encyclopedia of Indigenous Medicine 3Amazonian Tribe Creates First Encyclopedia of Indigenous Medicine 4Moleculera Labs Receives Grant from OCAST to Develop Assays to Identify Individuals with Neuropsychiatric Disorders of Autoimmune Origin 2Moleculera Labs Receives Grant from OCAST to Develop Assays to Identify Individuals with Neuropsychiatric Disorders of Autoimmune Origin 3PhUSE Delighted to Welcome Member Number 5.000 2Pistoia Alliance Continues to Attract New Members 2
... , ... market research report is available in its catalogue: , ... are assays that provide methods for quickly screening cell samples ... These assays inform drug development decisions by providing evidence of ...
... , SAN DIEGO, Dec. 8 Eidogen-Sertanty, Inc., ... they have licensed their Target Informatics Platform (TIP) to the ... (NCTR). , Under the terms of the license, scientists within ... knowledgebase via onlineTIP as well as access ...
... , ANNAPOLIS, Md., Dec. 7 PharmAthene, ... specializing in the development and commercialization of medical countermeasures ... Department of Health and Human Services Biomedical Research and ... (RFP) for Recombinant Protective Antigen Anthrax Vaccine for ...
Cached Biology Technology:Reportlinker Adds Pharmacodynamic Assays 2Reportlinker Adds Pharmacodynamic Assays 3Reportlinker Adds Pharmacodynamic Assays 4Eidogen-Sertanty Licenses TIP to the FDA 2BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines 2BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines 3BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines 4
(Date:6/25/2015)... , June 25, 2015  TAKE Solutions Ltd., a ... by the United States Patent and Trademark Office (USPTO) ... process leverages TAKE Solutions, Clinical Accelerators to reduce the ... (when compared to standardization without the accelerators), thus reducing ... At the heart of the patented ...
(Date:6/24/2015)... Research and Markets( ... "Huawei Ascend Mate 7 Fingerprint Sensor - ... Huawei,s technological choice for the fingerprint ... Apple,s and Samsung,s one. The Ascend Mate 7 ... Cards, a main actor in capacitive sensing human ...
(Date:6/23/2015)...   Valencell, a leader in performance ... recent study that illustrates its PerformTek biometric technology ... In a study conducted at Valencell,s Biometric Lab, ... Apple Watch against a chest strap – the ... The study demonstrated that Valencell,s biometric technology delivers ...
Breaking Biology News(10 mins):TAKE Solutions Awarded Patent By USPTO 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3
... meteorite fragments that fell on a frozen lake in ... life,s handedness why living things only use molecules ... evidence to date that liquid water inside an asteroid ... forms of some common protein amino acids in meteorites. ...
... days following the 2010 Deepwater Horizon oil spill, methane-eating ... the methane that gushed, along with oil, from the ... scientific curiosity: Prior to the oil spill, scientists had ... area. Now researchers at MIT have discovered a ...
... available in German . , Leipzig. Fungi ... threads. However, these networks have surprising functions. Only a few ... (UFZ) discovered that bacteria travel over the fungal threads through ... a highway. Now, together with British colleagues from the University ...
Cached Biology News:NASA and university researchers find a clue to how life turned left 2NASA and university researchers find a clue to how life turned left 3NASA and university researchers find a clue to how life turned left 4NASA and university researchers find a clue to how life turned left 5Newfound gene may help bacteria survive in extreme environments 2Newfound gene may help bacteria survive in extreme environments 3Newfound gene may help bacteria survive in extreme environments 4Contaminant transport in the fungal pipeline 2Contaminant transport in the fungal pipeline 3Contaminant transport in the fungal pipeline 4
Mouse monoclonal antibody raised against a full length recombinant CSNK2A2. NCBI Entrez Gene ID = CSNK2A2...
... Rockers, mini, SSM3 & SSM4, Small space saving ... action , Choice of two models: , - ... SSM4 , Digital speed control and built-in ... ,These compact rockers are ideal where gentle mixing ...
... The TargeTron(TM) Gene Knockout System provides ... and specific disruption of bacterial genes by ... exploits the retrohoming ability of group II ... to re-target the TargeTron group II intron ...
...
Biology Products: